The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Mylan NV

Nasdaq: MYL
Last

(U.S.) $41.83

Today's change+0.41 +0.98%
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.
 

Mylan NV

Nasdaq: MYL
Last

(U.S.) $41.83

Today's change+0.41 +0.98%
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.

Mylan NV up (U.S.)$0.41

Mylan NV closed up Friday by (U.S.)$0.41 or 0.98% to (U.S.)$41.83. Over the last five days, shares have lost 18.61% and are down 22.65% for the last year to date. This security has underperformed the S&P 500 by 12.56% during the last year.

Key company metrics

  • Open(U.S.) $41.34
  • Previous close(U.S.) $41.42
  • High(U.S.) $42.00
  • Low(U.S.) $40.05
  • Bid / Ask-- / --
  • YTD % change-22.65%
  • Volume15,531,140
  • Average volume (10-day)9,094,138
  • Average volume (1-month)6,742,150
  • Average volume (3-month)7,751,240
  • 52-week range(U.S.) $37.59 to (U.S.) $76.69
  • Beta1.41
  • Trailing P/E23.83×
  • P/E 1 year forward8.46×
  • Forward PEG0.66×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.76
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+9.35%

Based on its net profit margin of 9.35%, Mylan NV is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.43%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue2,6952,3721,8722,083
Total other revenue--------
Total revenue2,6952,3721,8722,083
Gross profit1,3201,015838982
Total cost of revenue1,3751,3571,0341,101
Total operating expense2,0932,0961,7191,697
Selling / general / administrative492501413349
Research & development174168152150
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)527012198
Other operating expenses, total0----0
Operating income602276152385
Interest income (expense), net non-operating-100-99-84-50
Gain (loss) on sale of assets--------
Other--------
Income before tax45518161272
Income after tax42916857191
Income tax, total2713582
Net income42916857189
Total adjustments to net income--------
Net income before extra. items42916857189
Minority interest000-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items42916857189
Inc. avail. to common incl. extra. items42916857189
Diluted net income42916857189
Dilution adjustment00--0
Diluted weighted average shares514522444401
Diluted EPS excluding extraordinary itemsvalue per share0.830.320.130.47
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.930.450.380.64